Form 4: Fulgent Genetics CFO Sells Shares for Tax Obligations

Fulgent Genetics CFO Paul Kim disposed of shares to cover tax liabilities arising from the vesting of restricted stock units.

Summary

• Paul Kim, Chief Financial Officer and Treasurer of Fulgent Genetics, Inc. (FLGT), reported the disposition of common stock.
• These dispositions were made to satisfy tax withholding obligations upon the vesting of previously granted restricted stock units (RSUs).
• On February 26, 2026, 1,168 shares were disposed of at a price of $24.76 per share, related to RSUs granted on February 26, 2024.
• On March 1, 2026, 1,133 shares were disposed of at $15.33 per share, related to RSUs granted on February 28, 2022.
• Also on March 1, 2026, an additional 8,347 shares were disposed of at $15.33 per share, related to RSUs granted on February 25, 2025.
• Following these transactions, Paul Kim beneficially owns 368,547 shares of Fulgent Genetics common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. It reports a routine, non-discretionary transaction by an insider to cover tax obligations upon RSU vesting, which does not reflect a change in sentiment about the company's prospects.

Positives

• The underlying event for these transactions is the vesting of restricted stock units, which represents earned compensation for the CFO.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

StockSavvy.ai notes that tax-related dispositions of shares by executives following RSU vesting are routine administrative transactions in the biotechnology and diagnostics industry, common across all sectors for executive compensation plans.

Stakeholder Impact

• Shareholders: Minimal impact, as these are routine tax-related dispositions and not discretionary sales indicating a change in insider sentiment.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary sale of shares by the CFO to cover tax liabilities associated with the vesting of restricted stock units. Such transactions are administrative in nature and do not typically signal a change in the company's fundamentals or management's outlook. Therefore, based solely on this filing, a seasoned investor would likely maintain their current position, hence a 'hold' recommendation.

Keywords

Fulgent Genetics, FLGT, Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Tax Withholding, CFO